Evofem Biosciences, Inc. (EVFM) Social Stream



Evofem Biosciences, Inc. (EVFM): $0.91

-0.22 (-19.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EVFM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Evofem Biosciences Inc (EVFM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EVFM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 4 $5 $0.8 $3.075 $0.37 731.08%
2021-12-15 4 $2 $0.75 $1.687 $0.37 355.95%
2022-01-31 4 $3 $0.75 $1.937 $0.37 423.51%
2022-03-03 4 $3 $0.53 $1.882 $0.37 408.65%

The Trend in the Analyst Price Target


EVFM's average price target has moved down $6.53 over the prior 13 months.

Over the past 133 days, EVFM's average upside potential has been 319.54%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-10-21 4 5 0.80 3.075 0.709 333.71%
2022-01-25 4 3 0.75 1.937 0.412 370.15%
2022-01-31 4 3 0.75 1.937 0.452 328.54%
2022-01-31 4 3 0.50 1.875 0.452 314.82%
2022-02-10 4 3 0.50 1.875 0.420 346.43%

EVFM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.83 3 0 0 1 1 4

The Trend in the Broker Recommendations


EVFM's average broker recommendation rating worsened by 0.33 over the prior 18 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • EVFM has a higher average analyst price target than 2.51% of all US stocks.
  • EVFM has a greater upside potential (average analyst target price relative to current price) than 478.51% of all US stocks.
  • In the context of stocks in the micro market cap category, Evofem Biosciences Inc's variance in analysts' estimates is lower than -363.7% of them.
  • In the context of Pharmaceutical Products stocks, Evofem Biosciences Inc's number of analysts covering the stock is greater than 114.9% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Evofem Biosciences Inc are ETTX, ETON, and EQ.

Is EVFM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4187 seconds.